Read More Pharma Industry News Harmony Biosciences faces FDA setback for pitolisant in idiopathic hypersomnia Harmony Biosciences Holdings, Inc. has encountered a regulatory hurdle in its efforts to expand the use of pitolisant… byPallavi MadhirajuFebruary 20, 2025